Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OutSee is a medical technology company focused on developing a non-invasive, wearable device for the treatment of glaucoma. The company's proprietary technology aims to lower intraocular pressure (IOP) by applying a physical stimulus to the eye, facilitating the drainage of aqueous humor without the need for daily eye drops or invasive surgical procedures. This approach is designed to improve patient adherence and provide a more consistent therapeutic effect compared to traditional pharmacological treatments. OutSee is currently advancing its lead device through clinical trials to validate its safety and efficacy in patients with open-angle glaucoma. The company was founded by experienced ophthalmologists and medical device entrepreneurs to address the significant unmet need for effective, non-pharmacological glaucoma management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OutSee.